IPO registrations (S-1, F-1) · Registrants
PROVECTUS BIOPHARMACEUTICALS, INC.
- SEC CIK
- 315545 · filings on EDGAR ↗
- Former names
- PROVECTUS PHARMACEUTICALS INC (2002–2013); PROVECTUS PHARMACEUTICAL INC (2002–2002); ZAMAGE DIGITAL IMAGING INC (2002–2002); SPM GROUP INC (2000–2001)
- Registration
- Form S-1, first filed 2009-05-01, last 2017-01-26; 2 initial registrations, 7 amendments
- Outcome
- Final prospectus filed 2017-01-31; declared effective 2009-06-11
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 800 S. GAY STREET, SUITE 1610, Knoxville, TN 37929
- EIN
- 90-0031917
- Ticker
- PVCT (OTC)
- EDGAR entity type
- operating
- Insiders and CEO pay
- PROVECTUS BIOPHARMACEUTICALS, INC. on the corporate pages
On this site
- Form 5500 plan sponsor: PROVECTUS PHARMACEUTICALS, INC. EXACT (EIN (EXACT))
- Form D issuer: PROVECTUS BIOPHARMACEUTICALS, INC. EXACT (CIK (EXACT))
- SEC filer: PROVECTUS BIOPHARMACEUTICALS, INC. EXACT (CIK (EXACT))
Filings 23
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2009-05-01 | S-1/A | S-1/A (amendment) | PROVECTUS PHARMACEUTICALS INC | 0001005794-09-000077 ↗ |
| 2009-06-11 | EFFECT | EFFECT (declared effective) | PROVECTUS PHARMACEUTICALS INC | 9999999995-09-001645 ↗ |
| 2010-07-14 | EFFECT | EFFECT (declared effective) | PROVECTUS PHARMACEUTICALS INC | 9999999995-10-002145 ↗ |
| 2010-08-05 | EFFECT | EFFECT (declared effective) | PROVECTUS PHARMACEUTICALS INC | 9999999995-10-002358 ↗ |
| 2011-08-05 | EFFECT | EFFECT (declared effective) | PROVECTUS PHARMACEUTICALS INC | 9999999995-11-002402 ↗ |
| 2012-07-20 | EFFECT | EFFECT (declared effective) | PROVECTUS PHARMACEUTICALS INC | 9999999995-12-002224 ↗ |
| 2013-04-08 | S-1 | S-1 (registration) | PROVECTUS PHARMACEUTICALS INC | 0001193125-13-146151 ↗ |
| 2013-04-09 | EFFECT | EFFECT (declared effective) | PROVECTUS PHARMACEUTICALS INC | 9999999995-13-000928 ↗ |
| 2013-04-09 | EFFECT | EFFECT (declared effective) | PROVECTUS PHARMACEUTICALS INC | 9999999995-13-000929 ↗ |
| 2013-04-15 | EFFECT | EFFECT (declared effective) | PROVECTUS PHARMACEUTICALS INC | 9999999995-13-001013 ↗ |
| 2015-07-27 | EFFECT | EFFECT (declared effective) | PROVECTUS BIOPHARMACEUTICALS, INC. | 9999999995-15-002072 ↗ |
| 2016-01-15 | EFFECT | EFFECT (declared effective) | PROVECTUS BIOPHARMACEUTICALS, INC. | 9999999995-16-003533 ↗ |
| 2016-05-11 | EFFECT | EFFECT (declared effective) | PROVECTUS BIOPHARMACEUTICALS, INC. | 9999999995-16-004615 ↗ |
| 2016-05-27 | EFFECT | EFFECT (declared effective) | PROVECTUS BIOPHARMACEUTICALS, INC. | 9999999995-16-004773 ↗ |
| 2016-10-05 | S-1 | S-1 (registration) | PROVECTUS BIOPHARMACEUTICALS, INC. | 0001193125-16-731651 ↗ |
| 2016-11-01 | S-1/A | S-1/A (amendment) | PROVECTUS BIOPHARMACEUTICALS, INC. | 0001193125-16-755423 ↗ |
| 2016-11-22 | S-1/A | S-1/A (amendment) | PROVECTUS BIOPHARMACEUTICALS, INC. | 0001193125-16-775221 ↗ |
| 2016-12-06 | S-1/A | S-1/A (amendment) | PROVECTUS BIOPHARMACEUTICALS, INC. | 0001193125-16-786463 ↗ |
| 2016-12-21 | S-1/A | S-1/A (amendment) | PROVECTUS BIOPHARMACEUTICALS, INC. | 0001193125-16-800197 ↗ |
| 2017-01-19 | S-1/A | S-1/A (amendment) | PROVECTUS BIOPHARMACEUTICALS, INC. | 0001193125-17-013156 ↗ |
| 2017-01-26 | S-1/A | S-1/A (amendment) | PROVECTUS BIOPHARMACEUTICALS, INC. | 0001193125-17-019927 ↗ |
| 2017-01-27 | EFFECT | EFFECT (declared effective) | PROVECTUS BIOPHARMACEUTICALS, INC. | 9999999995-17-000223 ↗ |
| 2017-01-31 | 424B4 | 424B4 (final prospectus) | PROVECTUS BIOPHARMACEUTICALS, INC. | 0001193125-17-024216 ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| CULPEPPER PETER R | Officer; Other | CFO & COO; CFO, COO; Chief Financial Officer; Interim CEO, CFO, COO | 33 | 2006–2017 | |
| WACHTER ERIC PHD | Director,Officer; Officer | Chief Technology Officer; CTO; Executive VP Pharmaceuticals; Vice President Pharmaceuticals | 46 | 2006–2024 | |
| ADAMS DONALD E | TenPercentOwner | 4 | 2006–2007 | ||
| DEES H CRAIG | Director,Officer | CEO; Chief Executive Officer | 23 | 2006–2015 | |
| SCOTT TIMOTHY PHD | Director,Officer; Officer | President | 19 | 2006–2015 | |
| FUCHS STUART | Director | 7 | 2006–2011 | ||
| McMasters Kelly M | Director | 9 | 2008–2015 | ||
| Smith Alfred E. IV | Director | 6 | 2011–2015 | ||
| Koe Jan | Director | 7 | 2012–2016 | ||
| Glass John R | Officer | See Remarks | 2 | 2016–2017 | |
| Horowitz Bruce | Director; Director,Officer | Chief Operating Officer; COO | 4 | 2017–2021 | |
| Rodrigues Dominic | Director; Director,Officer | President; PRESIDENT | 6 | 2017–2026 | |
| Lacey John III | Director | 5 | 2018–2026 | ||
| Pershing Edward | Director; Director,Officer; Director,Officer,TenPercentOwner | CEO | 134 | 2018–2026 | |
| Raines Heather | Officer | CFO; Chief Financial Officer | 8 | 2019–2024 | |
| Bailey Webster | Director | 5 | 2020–2026 | ||
| Morris Jeffrey Allen | TenPercentOwner | 4 | 2023–2024 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2024-07-17 | PROVECTUS BIOPHARMACEUTICALS, INC. | Pharmaceuticals | $10,000,000 | $0 | 0 | 1 |
| 2022-10-28 | PROVECTUS BIOPHARMACEUTICALS, INC. | Pharmaceuticals | $5,000,000 | $317,500 | 2 | 1 |
| 2021-08-30 | PROVECTUS BIOPHARMACEUTICALS, INC. | Pharmaceuticals | $5,000,000 | $200,000 | 1 | 1 |
| 2014-10-15 | PROVECTUS BIOPHARMACEUTICALS, INC. | Pharmaceuticals | $15,000,000 | $0 | 0 | 1 |
| 2014-04-17 | PROVECTUS BIOPHARMACEUTICALS, INC. | Pharmaceuticals | $5,000,000 | $3,373,250 | 17 | 1 |
| 2012-03-22 | PROVECTUS PHARMACEUTICALS INC | Pharmaceuticals | $2,499,999 | $499,999 | 6 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.